Robert A Stewart insider trades

Open-market stock purchases and sales by Robert A Stewart, Director at CorMedix Inc, from SEC Form 4 filings since Feb 24, 2010.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +79%.

Recent trades

DateStockTradeValue
Jan 26, 2026CRMD CorMedix IncBought (not open market)—

Companies traded

  • CRMD CorMedix Inc: 1 buy, last Jan 26, 2026
  • AMRX Amneal Pharmaceuticals, Inc: 1 buy, last May 7, 2019
  • AGN Allergan plc: other filings, last Dec 29, 2017
  • ACT Actavis plc: 4 sales, last Mar 5, 2015
  • WPI Watson Pharmaceuticals Inc: other filings, last Oct 31, 2012

Get free alerts when Robert A Stewart files a new trade →